[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
September 2015

Zonular Dehiscence at the Time of Combined Vitrectomy and Cataract Surgery After Intravitreal Ocriplasmin Injection

Author Affiliations
  • 1Vitreo-Retinal Surgery Service, Bristol Eye Hospital, Bristol, United Kingdom
JAMA Ophthalmol. 2015;133(9):1091-1092. doi:10.1001/jamaophthalmol.2015.1680

Ocriplasmin is a recombinant fraction of plasmin with nonspecific protease activity capable of cleaving fibronectin and laminin. It has recently been approved for the treatment of vitreomacular traction and associated macular holes (MHs). Clinical trials1 report good clinical results and safety profile. We report 2 cases that developed zonular dehiscence at the time of vitrectomy and intraocular lens (IOL) implantation after treatment with ocriplasmin.

First Page Preview View Large
First page PDF preview
First page PDF preview